Madrigal Pharmaceuticals Inc

NASDAQ:MDGL   4:00:00 PM EDT
204.65
-13.73 (-6.29%)
5:51:02 PM EDT: $203.00 -1.65 (-0.81%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Madrigal Pharmaceuticals Inc Stock, NASDAQ:MDGL

200 Barr Harbor Drive, Suite 200, West Conshohocken, Pennsylvania 19428
United States of America
Phone: +1.267.824.2827
Number of Employees: 376
http://www.madrigalpharma.com

Description

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.